Chemomab Therapeutics Ltd. buy BiotechBee
Start price
08.09.24
/
50%
€1.74
Target price
29.11.26
€3.20
Performance (%)
-12.64%
End price
14.12.24
€1.52
Summary
This prediction ended on 14.12.24 with a price of €1.52. The prediction for Chemomab Therapeutics Ltd. disappointed with a performance of -12.64%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Chemomab Therapeutics Ltd. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Chemomab Therapeutics Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Chemomab Therapeutics Ltd. diskutieren
In the thread Trading Chemomab Therapeutics Ltd.
Stopped prediction by BiotechBee for Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.19
09.03.25
09.03.25
€2.50
31.07.27
31.07.27
-16.39%
30.03.25
30.03.25
Could be very worthwhile Investment >20% year
